ASML Adds 1% as 110 EUV Tools Test Factory Throughput - TradingView

ASML's near-1% gain to $1,696 underscores a market pricing in a capacity story rather than a technology breakthrough. The roadmap to deliver 110+ EUV systems by 2028—up from a stated floor of 80 in 20... Read original →

The 1% pop to $1,696 is a misread. The market isn't pricing a technology inflection—it's underwriting a capacity monopoly. The 110-unit EUV roadmap by 2028 (versus 80 in 2027) is a 37.5% output jump for what remains the most complex capital good in semiconductors. Upstream, the real constraint isn't ASML's assembly floor. It's Zeiss's ZEWRO optical grinding cycles and Cymer's 350W laser source yield curves. Downstream, every additional EUV tool directly gates 3nm/2nm wafer starts at TSMC (Taiwan, China), Samsung, and Intel. ASML is, functionally, the single chokepoint in the AI accelerator supply chain. The execution asymmetry is the underpriced risk. EUV systems require 6-8 months of on-site installation, customer-specific calibration, and acceptance testing. Scaling to 110 concurrent deployments means managing dozens of parallel qualification streams—a single yield excursion triggers industry-wide line stoppages. On competition: Nikon and Canon remain irrelevant at EUV. The genuine strategic threat is AI capex mean-reversion. At 34% above GF Value, the stock has already front-loaded the 2028 delivery narrative. If inference demand decelerates in 2026, the 80-to-110 step-up becomes overcapacity, not growth. The margin for slippage is essentially zero.